Differential Nocturnal Diuresis Rates Among Patients with and Without Nocturnal Polyuria Syndrome.


Journal

European urology focus
ISSN: 2405-4569
Titre abrégé: Eur Urol Focus
Pays: Netherlands
ID NLM: 101665661

Informations de publication

Date de publication:
15 03 2020
Historique:
received: 26 09 2018
revised: 12 10 2018
accepted: 29 10 2018
pubmed: 6 11 2018
medline: 21 5 2021
entrez: 6 11 2018
Statut: ppublish

Résumé

The mechanism of nocturnal polyuria (NP), a leading cause of nocturia, is poorly understood. To characterize NP in terms of diuresis rate changes before and after the first nocturnal awakening. A frequency-volume chart (FVC) database of 773 entries from 440 veterans treated at a Veterans Affairs urology clinic was analyzed. The first FVCs completed by male patients aged ≥18 years with two or more nocturnal voids were included. Patients were excluded if they were taking diuretics or had sleep apnea, heart failure, edema, kidney disease, or diabetes insipidus. The 130 included individuals were divided into two cohorts: patients with NP and patients below this threshold. Analyses were performed using two different cutoffs for NP: nocturnal urine production (NUP) >90ml/h and nocturnal polyuria index (NPi) >0.33. We compared "early nocturnal diuresis rate" (ENDR; first nocturnal voided volume/length of first uninterrupted sleep period), "late nocturnal diuresis rate" (LNDR; remaining nocturnal urine volume/remaining hours of sleep), and diurnal diuresis rate (daytime urine volume/hours awake) in patients with the nocturnal polyuria syndrome (NPS). Within groups, there were significant differences between ENDR and LNDR for NPS patients at NUP >90ml/h (152 vs 120ml/h, p=0.02) and NPi >0.33 (120 vs 91ml/h, p=0.02) but not for those without NPS at NUP ≤90ml/h (60 vs 59ml/h, p=0.29) or NPi ≤0.33 (75 vs 75ml/h, p=0.25). Limitations include retrospective design, single institution participation, and small sample size. There exists a significant drop-off in nocturnal diuresis rate after the time of first awakening that is unique to patients with NPS. The large volume of urine produced in the early hours of sleep may provide the specific substrate for short-acting antidiuretics approved for use in patients with nocturia owing to NPS. We analyzed adult males diagnosed with nocturnal polyuria syndrome to determine how their rate of urine production changed throughout the night. Our finding that these individuals produce urine at the highest rate in the early hours of sleep suggests that they may benefit from pharmaceuticals specifically designed to reduce urine production during this period.

Sections du résumé

BACKGROUND
The mechanism of nocturnal polyuria (NP), a leading cause of nocturia, is poorly understood.
OBJECTIVE
To characterize NP in terms of diuresis rate changes before and after the first nocturnal awakening.
DESIGN, SETTING, AND PARTICIPANTS
A frequency-volume chart (FVC) database of 773 entries from 440 veterans treated at a Veterans Affairs urology clinic was analyzed. The first FVCs completed by male patients aged ≥18 years with two or more nocturnal voids were included. Patients were excluded if they were taking diuretics or had sleep apnea, heart failure, edema, kidney disease, or diabetes insipidus. The 130 included individuals were divided into two cohorts: patients with NP and patients below this threshold. Analyses were performed using two different cutoffs for NP: nocturnal urine production (NUP) >90ml/h and nocturnal polyuria index (NPi) >0.33.
OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS
We compared "early nocturnal diuresis rate" (ENDR; first nocturnal voided volume/length of first uninterrupted sleep period), "late nocturnal diuresis rate" (LNDR; remaining nocturnal urine volume/remaining hours of sleep), and diurnal diuresis rate (daytime urine volume/hours awake) in patients with the nocturnal polyuria syndrome (NPS).
RESULTS AND LIMITATIONS
Within groups, there were significant differences between ENDR and LNDR for NPS patients at NUP >90ml/h (152 vs 120ml/h, p=0.02) and NPi >0.33 (120 vs 91ml/h, p=0.02) but not for those without NPS at NUP ≤90ml/h (60 vs 59ml/h, p=0.29) or NPi ≤0.33 (75 vs 75ml/h, p=0.25). Limitations include retrospective design, single institution participation, and small sample size.
CONCLUSIONS
There exists a significant drop-off in nocturnal diuresis rate after the time of first awakening that is unique to patients with NPS. The large volume of urine produced in the early hours of sleep may provide the specific substrate for short-acting antidiuretics approved for use in patients with nocturia owing to NPS.
PATIENT SUMMARY
We analyzed adult males diagnosed with nocturnal polyuria syndrome to determine how their rate of urine production changed throughout the night. Our finding that these individuals produce urine at the highest rate in the early hours of sleep suggests that they may benefit from pharmaceuticals specifically designed to reduce urine production during this period.

Identifiants

pubmed: 30392866
pii: S2405-4569(18)30316-X
doi: 10.1016/j.euf.2018.10.015
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

320-326

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Auteurs

Thomas F Monaghan (TF)

Department of Urology, SUNY Downstate Medical Center, Brooklyn, NY, USA. Electronic address: monaghantf@gmail.com.

Nicholas R Suss (NR)

Department of Urology, SUNY Downstate Medical Center, Brooklyn, NY, USA.

Matthew R Epstein (MR)

Department of Urology, SUNY Downstate Medical Center, Brooklyn, NY, USA.

Viktor X Flores (VX)

Department of Urology, SUNY Downstate Medical Center, Brooklyn, NY, USA.

Zhan D Wu (ZD)

Department of Urology, SUNY Downstate Medical Center, Brooklyn, NY, USA.

Kyle P Michelson (KP)

Department of Urology, SUNY Downstate Medical Center, Brooklyn, NY, USA.

François Hervé (F)

Urology Department, Ghent University Hospital, Ghent, Belgium.

Donald L Bliwise (DL)

Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.

Karel Everaert (K)

Urology Department, Ghent University Hospital, Ghent, Belgium.

Jeffrey P Weiss (JP)

Department of Urology, SUNY Downstate Medical Center, Brooklyn, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH